A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells

12Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of de novo fatty acid synthesis, respectively. Although their antitumor effects have been explored in detail, the potential inhibition of the malignant metabolic phenotype and its influence on the expression of chemokines and growth factors involved in colon cancer, have not been previously reported to the best of our knowledge. In the present study, dose-response curves with orlistat, lonidamine or DON were generated from cell viability assays conducted in SW480 colon cancer cells. In addition, the synergistic effect of these compounds was evaluated in SW480 human colon cancer cells. The determination of the doses used for maximum synergistic efficacy led to the exploration of the mRNA levels of the target genes hexoki‑ nase‑2 (HK2), glutaminase‑1 (GLS‑1) and fatty acid synthase (FASN) in human SW480 and murine CT26.WT colon cancer cells. The cell viability was evaluated following transfection with small interfering (si)RNA targeting these genes and was assessed with trypan blue. The expression levels of chemokines and growth factors were quantified in the supernatant of SW480 cells with LEGENDplex™. The combination of lonidamine, DON and orlistat resulted in a synergistic cytotoxic effect and induced the transcription of the corresponding gene targets but their corresponding proteins were actually downregulated. The downregulation of the expression levels of HK2, GLS‑1 and FASN following transfection of the cells with the corresponding siRNA sequences decreased their viability. The treatment significantly reduced the expression levels of 9 chemokines [interleukin-9, C-X-C motif chemokine ligand (CXCL) 10, eotaxin, chemokine ligand (CCL) 9, CXCL5, CCL20, CXCL1, CXCL11 and CCCL4] and one growth factor (stem cell factor). These changes were associated with decreased phosphorylated-nuclear factor κB-p65. The data demonstrate that lonidamine, DON and orlistat in combination reduce the expression levels of chemokines and growth factors in colon cancer cells. Additional research is required to investigate the exact way by which both tumor and stromal cells regulate the expression levels of chemokines and growth factors.

References Powered by Scopus

Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-ΔΔC</sup>T method

149974Citations
N/AReaders
Get full text

The Emerging Hallmarks of Cancer Metabolism

4085Citations
N/AReaders
Get full text

Missing pieces in the NF-κB puzzle

3405Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Chemokines in colon cancer progression

86Citations
N/AReaders
Get full text

Redox homeostasis and metabolism in cancer: A complex mechanism and potential targeted therapeutics

66Citations
N/AReaders
Get full text

Nanosystem-mediated lactate modulation in the tumor micro environment for enhanced cancer therapy

11Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Schcolnik-Cabrera, A., Dominguez-Gómez, G., Chávez-Blanco, A., Ramírez-Yautentzi, M., Morales-Bárcenas, R., Chávez-Díaz, J., … Dueñas-González, A. (2019). A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells. Oncology Letters, 18(6), 6909–6916. https://doi.org/10.3892/ol.2019.11008

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Researcher 2

33%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

67%

Medicine and Dentistry 1

17%

Pharmacology, Toxicology and Pharmaceut... 1

17%

Save time finding and organizing research with Mendeley

Sign up for free